Jagadeesh Prasad Dasappa

Dr. Jagadeesh Prasad Dasappa


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 October 2019 in Acta Crystallographica Section E Crystallographic Communications
Verified
Journal Article
Open access
PDF file
HKHussien Ahmed Khamees
Hussien Ahmed Khamees
KCKumara Chaluvaiah
Kumara Chaluvaiah
NENasseem Ahmed El-Khatatneh
Nasseem Ahmed El-Khatatneh
ASAnanda Swamynayaka
Ananda Swamynayaka
HKHuey Chong Kwong
Huey Chong Kwong
MMMahendra Madegowda
Mahendra Madegowda
The title imidazo[1,2-a] pyridine derivative, C13H8Br2N2, was synthesizedviaa single-step reaction method. The title molecule is planar, showing a dihedral angle of 0.62 (17)° between the phenyl and the imidazo[1,2-a] pyridine rings. An intramolecular C—H...N hydrogen bond with anS(5) ring motif is present. In the crystal, a short H...H contact links adjacent molecules into inversion-related dimers. The dimers are linked in turn by weak C—H...π and slipped π–π stacking interactions, forming layers parallel to (110). The layers are connected into a three-dimensional network by short Br...H contacts. Two-dimensional fingerprint plots and three-dimensional Hirshfeld surface analysis of the intermolecular contacts reveal that the most important contributions for the crystal packing are from H...Br/Br...H (26.1%), H...H (21.7%), H...C/C...H (21.3%) and C...C (6.5%) interactions. Energy framework calculations suggest that the contacts formed between molecules are largely dispersive in nature. Analysis of HOMO–LUMO energies from a DFT calculation reveals the pure π character of the aromatic rings with the highest electron density on the phenyl ring, and σ character of the electron density on the Br atoms. The HOMO–LUMO gap was found to be 4.343 eV.

9 May 2021 in Journal of Materials Science: Materials in Electronics
Verified
Journal Article
Closed access
PDF file
SAS. Ananda
S. Ananda
HKHussien Ahmed Khamees
Hussien Ahmed Khamees
MMM. Mahendra
M. Mahendra
CKC. Kumara
C. Kumara
JDJagadeesh Prasad Dasappa
Jagadeesh Prasad Dasappa
GVG. Vinitha
G. Vinitha

24 September 2015 in Medicinal Chemistry Research
Verified
Journal Article
Closed access
PDF file
PCPrakash Anil Castelino
Prakash Anil Castelino
JDJagadeesh Prasad Dasappa
Jagadeesh Prasad Dasappa
KBKishore G. Bhat
Kishore G. Bhat
SJSumith Ashok Joshi
Sumith Ashok Joshi
SJSunil S Jalalpure
Sunil S Jalalpure

13 February 2019 in Journal of Chemical Sciences
Verified
Journal Article
Closed access
PDF file
SBShrikanth K Bhat
Shrikanth K Bhat
JDJagadeesh Prasad Dasappa
Jagadeesh Prasad Dasappa
MHM S Hegde
M S Hegde

1 September 2014 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
PCPrakash Anil Castelino
Prakash Anil Castelino
PNPrashantha Naik
Prashantha Naik
JDJagadeesh Prasad Dasappa
Jagadeesh Prasad Dasappa
RSR.S. Sujayraj
R.S. Sujayraj
KCK. Sharath Chandra
K. Sharath Chandra
SASatish Kumar Adiga
Satish Kumar Adiga

7 December 2020 in New Journal of Chemistry
Verified
Journal Article
Closed access
PDF file
SKSandhya Kumari
Sandhya Kumari
SKSukumar Kotyan
Sukumar Kotyan
SSSinoy Sugunan
Sinoy Sugunan
GRG. K. Rajanikant
G. K. Rajanikant
SSSharath Kumar K S
Sharath Kumar K S
GKGuruprasad Kalthur
Guruprasad Kalthur
Poor sperm motility is one of the major causes of male infertility and fertilization failure in assisted reproductive technology (ART). Pentoxifylline (PTF), a phosphodiesterase inhibitor (PDEI), has been used previously in ART to enhance sperm motility. However, reports on its adverse effects on sperm function and early embryo development have resulted in a need to find safe alternative molecules. The aim of the present study was to synthesize various structurally modified pentoxifylline (mPTF) compounds and then screen them to determine if they possess a beneficial role in enhancing human sperm motility. A series of 3,7-dimethyl-1-[(6E)-5-oxo-7-aryllhept-6-en-1-yl]-3,7-dihydro-1H-purine-2,6-diones (mPTF1-mPTF6) was synthesized via treating PTF with various arylaldehydes in the presence of alcoholic KOH solution. The structures of the novel compounds were confirmed via Fourier transform infrared spectroscopy (FT-IR) (without the KBr method), 1H-NMR, 13C-NMR, and liquid chromatography (LC)-mass spectrometry studies. These compounds were screened for their human sperm motility enhancement properties. Among the six compounds, 1-[(6E)-7-(6-methoxynaphthyl)-5-oxohept-6-en-1-yl]-3,7-dimethyl-3,7-dihydro-1H-purine-2,6-dione (mPTF1) exhibited superior motility enhancement and prolonged survival in vitro in comparison to PTF. The optimum activity of mPTF1 was observed at a concentration that was four times lower (0.25 mM) than the parent compound (1 mM), indicating its increased efficiency. Comparative cytotoxicity and genotoxicity assays revealed that mPTF1 has significantly lower genotoxicity than the parent molecule PTF. Overall, the results indicated that the structural modification of PTF can increase sperm motility and its longevity in vitro. The modification also resulted in reduced genotoxic effects. Therefore, mPTF1 may have better therapeutic potential than the parent compound PTF in ART.